Chronic Heart Failure Flashcards
(82 cards)
Etiology of HF
Heart is not able to apply sufficient oxygen rich blood to the body because of impaired ability of the left ventricle to fill or eject blood
Diagnosis ejection fraction
echocardiogram
LVEF ≥50
HFpEF: impaired ventricular relaxation and filling during diastole
41-49% EF
HFmrEF
What is HFimpEF
≤40% at baseline but improves to >40%
LVEF ≤40%
HFpEF: impaired ability to eject blood during systole
What is the ACC/AHA staging
Structural classification
A: Patient is at risk with no sx
B: Pre-HF with structural heart disease with no signs of sx
C: Structural abnormalities with sx
D: Advanced (refractory) HF requiring hospitalization (ADHF)
What are the NYHA functional classes?
I: No limitations to physical activity
II: Slight limitation but ordinary activity → sx of HF
III: Marked limitations with minimal exertion
IV: Unable to carry out physical activity without sx of HF or sx at rest
What are labs of HF
BNP >100
NT-proBNP >300
Sx of left sided HF
Orthopnea: SOB when lying flat
Paroxysmal nocturnal dyspepsia: nocturnal cough and SOB
Rales: crackling
S3 gallop
Hypoperfusion: renal impairment or cool extremities
General sx of HF
Dyspepsia
Cough
Fatigue, weakness
Reduced exercise capacity
Sx of right sided HF
Peripheral edema
Ascites
JVD
HJR
Hepatomegaly
What is cardiac output
Volume of blood that is pumped by the heart in 1 min
CO = HR x SV
How to calculate Cardiac index
CI = CO/BSA
Describe the compensatory mechanism of HFrEF
Low cardiac output → activation of neurohormonal pathways (RAAS) → ↑ blood volume and force of contraction → chronic compensation leads to cardiac remodeling
Activity of Ang2
Vasoconstriction → release aldosterone and vasopressin
Activity of aldosterone
Sodium and water retention
Activity of vasopressin
Vasoconstriction and water retention
Lifestyle counseling of HF
- Monitor body weight
- Notify provider if weight ↑ 2-4 lbs in one day or ≥5 lbs in a week
- Avoid sodium ≤1.5g/day
- Restrict fluid 1.5-2L
Natural products used for HF
CoEnzyme Q10
Hawthorn
Omega 3 FA
Drugs that worsen HF
DDP-4 (alogliptin and saxagliptin)
Immunosuppressants (TNF inhibitors)
Non-DHP CCB
Antiarrhythmics (CI, amiodarone, and dofetalide)
TZDs
Itraconazole
Oncology drugs (Doxorubicin and daunarubicin)
NSAIDs
What are the GDMT drugs
ARNI, ACEI, or ARB: reduce mortality and morbidity
BB: reduce mortality and hospitalizations
MRAs: reduce morbidity and mortality
SGLT2I: reduce hospitalization and mortality
Medication that is preferred in HFmrEF?
SGLT2i
MOA of entresto
Sacubitril: neprilysin inhibitor, an enzyme responsible for degradation of vasodilatory peptides (BNP)